Category: Insulet Corp.
Top execs from Haemonetics, Kips Bay and others open up about their biggest regrets, debate market pressures facing the medtech industry and offer advice for young entrepreneurs.
A group of medtech insiders gathered in Boston last night to talk shop, share stories and glean insight from some of the industry's brightest minds at MassDevice's DeviceTalks East conference.
Insulet says it agreed to settle a patent infringement lawsuit brought by Becton, Dickinson for $5 million.
After breaking up last year, Insulet and DexCom come together again to integrate insulin pump devices with mobile apps that aggregate and display important data for patients with diabetes.
Abbott Diabetes Care recalls FreeStyle and FreeStyle Flash blood glucose meters users over concerns that the devices may report erroneously low readings.
Updated March 17, 2014, at 4:30 pm. with comments from Abbott.
Diabetes devices maker Insulet posts a stellar quarter that beats Wall Street's expectations and notes a pending Massachusetts Attorney General inquiry.
Massachusetts-based Insulet (NSDQ:PODD) got some Wall Street love today after posing a significant bump in sales for its 4th quarter and the full year of 2013.
Insulet plans an expansion into new headquarters, moving from Bedford, Mass., to nearby Billerica.
Insulet (NSDQ:PODD) is moving its corporate headquarters to Billerica, Mass., 9 minutes away from the company's current home in Bedford, Mass.
Insulin pump maker Insulet plans to add another 20 sales reps to its team by the end of Q1, as the company continues to see major growth in pediatric users of its tubeless OmniPod system.
Insulet (NSDQ:PODD) president & CEO Duane DeSisto is looking for a few good reps, planning to add 20 members to the company's sales force by the end of the 1st quarter.